Bioventus Inc
BVS6.455USD
+0.275+4.45%
交易中 （美東）報價延遲15分鐘
427.52M總市值
虧損本益比TTM
關於 Bioventus Inc 公司
Bioventus Inc. 是一家醫療器械公司。該公司專注於開發和商業化臨牀差異化和微創治療，以參與和增強人體的自然癒合過程。其產品組合分爲三個領域。其疼痛治療包括非手術疼痛注射療法以及外周神經刺激 (PNS) 產品，以幫助患者恢復正常活動。其外科解決方案包括骨移植替代品 (BGS)，可增加骨骼形成以刺激脊柱融合和其他骨科手術中的骨骼癒合，以及用於精確骨骼切割和雕刻、軟組織管理和各種手術中的組織清創的超聲波產品組合。其恢復療法包括骨刺激系統，以及旨在幫助患者因中風、多發性硬化症或其他中樞神經系統疾病恢復腿部或手部功能的設備。
公司簡介
公司代碼BVS
公司名稱Bioventus Inc
上市日期Feb 11, 2021
CEOMr. Robert E. Claypoole
員工數量930
證券類型Ordinary Share
年結日Feb 11
公司地址4721 Emperor Boulevard, Suite 100
城市DURHAM
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編27703
電話19194746700
網址https://www.bioventus.com/
公司代碼BVS
上市日期Feb 11, 2021
CEOMr. Robert E. Claypoole
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
74.70K
+54.96%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Mr. Mark Singleton
Mr. Mark Singleton
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Pain Treatments and Joint Preservation
58.92M
47.56%
Surgical solutions
45.23M
36.52%
Restorative Therapies
19.72M
15.92%
地區USD
名稱
營收
佔比
United States
110.52M
89.22%
International
13.36M
10.78%
業務
地區
業務USD
名稱
營收
佔比
Pain Treatments and Joint Preservation
58.92M
47.56%
Surgical solutions
45.23M
36.52%
Restorative Therapies
19.72M
15.92%
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
EW Healthcare Partners
19.62%
Juniper Investment Company, LLC
10.46%
Smith & Nephew Group plc
9.39%
Nantahala Capital Management, LLC
6.22%
BlackRock Institutional Trust Company, N.A.
3.85%
Other
50.46%
持股股東
持股股東
佔比
EW Healthcare Partners
19.62%
Juniper Investment Company, LLC
10.46%
Smith & Nephew Group plc
9.39%
Nantahala Capital Management, LLC
6.22%
BlackRock Institutional Trust Company, N.A.
3.85%
Other
50.46%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
24.76%
Venture Capital
19.62%
Investment Advisor
16.38%
Hedge Fund
9.46%
Corporation
9.39%
Individual Investor
2.56%
Research Firm
1.23%
Bank and Trust
0.33%
Pension Fund
0.21%
Other
16.06%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
315
55.71M
83.95%
-8.66M
2025Q1
320
55.18M
83.57%
-8.66M
2024Q4
318
53.79M
82.30%
-10.70M
2024Q3
319
53.14M
81.61%
-8.49M
2024Q2
288
54.91M
84.63%
-3.42M
2024Q1
287
52.64M
83.27%
-7.74M
2023Q4
285
51.63M
82.02%
-9.27M
2023Q3
276
51.61M
82.33%
-9.01M
2023Q2
273
50.56M
81.06%
-10.51M
2023Q1
271
49.55M
80.44%
-9.36M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
EW Healthcare Partners
13.02M
19.62%
--
--
Mar 31, 2025
Juniper Investment Company, LLC
6.94M
10.46%
--
--
Mar 31, 2025
Smith & Nephew Group plc
6.23M
9.39%
--
--
Apr 07, 2025
Nantahala Capital Management, LLC
4.13M
6.22%
+98.84K
+2.45%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.56M
3.85%
-7.24K
-0.28%
Mar 31, 2025
The Vanguard Group, Inc.
2.55M
3.84%
+92.14K
+3.76%
Mar 31, 2025
Divisadero Street Capital Management, LP
1.69M
2.55%
+1.69M
--
Mar 31, 2025
Driehaus Capital Management, LLC
1.45M
2.18%
+325.40K
+29.06%
Mar 31, 2025
American Century Investment Management, Inc.
1.04M
1.57%
+159.54K
+18.03%
Mar 31, 2025
Fidelity Management & Research Company LLC
998.35K
1.5%
+29.40K
+3.03%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Harbor Human Capital Factor US Small Cap ETF
0.17%
Lattice Hartford Multifactor Small Cap ETF
0.12%
VictoryShares Small Cap Free Cash Flow ETF
0.09%
Vanguard US Multifactor ETF
0.08%
Fidelity Enhanced Small Cap ETF
0.08%
iShares Micro-Cap ETF
0.07%
Avantis US Small Cap Value ETF
0.04%
Humankind US Stock ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Equity ETF
0.03%
查看更多
Harbor Human Capital Factor US Small Cap ETF
佔比0.17%
Lattice Hartford Multifactor Small Cap ETF
佔比0.12%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.09%
Vanguard US Multifactor ETF
佔比0.08%
Fidelity Enhanced Small Cap ETF
佔比0.08%
iShares Micro-Cap ETF
佔比0.07%
Avantis US Small Cap Value ETF
佔比0.04%
Humankind US Stock ETF
佔比0.03%
WisdomTree US SmallCap Fund
佔比0.03%
Avantis US Small Cap Equity ETF
佔比0.03%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
